Share ownership Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 17/06/2025 BST			After hours 00:59:16
791.24 ^USD	-2.02%		794.22	+0.38%

06-17	Health Care Down as Biotech Slides -- Health Care Roundup	DJ
06-17	Indexes end lower as Israel-Iran fighting raises investor anxiety	RE

Share class: Eli Lilly and Company

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	949,680,694	947,847,779 ( 99.81 %)	365,000 ( 0.0384 %)	99.81 %

Major shareholders: Eli Lilly and Company

Name	Equities	%	Valuation
Lilly Endowment, Inc. 10.13 %	96,016,978	10.13 %	70 829 M $
Lilly Endowment, Inc. 10.13 %	96,016,978	10.13 %	70 829 M $
Vanguard Fiduciary Trust Co. 8.359 %	79,224,392	8.359 %	58 441 M $
PNC Investments LLC 5.39 %	51,086,636	5.39 %	37 685 M $
BlackRock Advisors LLC 5.251 %	49,767,892	5.251 %	36 712 M $
State Street Corp. 3.634 %	34,437,950	3.634 %	25 404 M $
Fidelity Management & Research Co. LLC 3.002 %	28,451,100	3.002 %	20 988 M $
T. Rowe Price International Ltd. 2.019 %	19,133,284	2.019 %	14 114 M $
Geode Capital Management LLC 1.955 %	18,526,249	1.955 %	13 666 M $
Capital Research & Management Co. (World Investors) 1.94 %	18,382,573	1.94 %	13 560 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.001418 %	403,500	0.001418 %	10 M $
BRAM - Bradesco Asset Management SA DTVM 0.000177 %	50,305	0.000177 %	1 M $
XP Allocation Asset Management Ltda. 0.000015 %	4,284	0.000015 %	105 694 $
BTG Pactual WM Gestão de Recursos Ltda. 0.000008 %	2,220	0.000008 %	54 771 $
Morgan Stanley Administradora de Carteiras SA 0.000004 %	1,000	0.000004 %	24 672 $

Breakdown by shareholder type

Institutional	81.87%
Other	6.23%
State Street Corp.	3.63%
Schweizerische Nationalbank	0.24%
Sumitomo Mitsui Trust Group, Inc.	0.21%
Manulife Financial Corp.	0.17%
Individuals	0.16%
Governments	0.12%
Swedbank AB	0.12%
SEI Investments Co.	0.07%
Fifth Third Bancorp	0.05%
Regions Financial Corp.	0.04%
Skandinaviska Enskilda Banken AB	0.03%
The Bank of Nova Scotia	0.03%
Menora Mivtachim Holdings Ltd.	0.03%
Zurich Insurance Group AG	0.02%
Rathbones Group Plc	0.02%
Corebridge Financial, Inc.	0.02%
Clal Insurance Enterprises Holdings Ltd.	0.01%
Associated Banc-Corp	0.01%
Peapack-Gladstone Financial Corp.	0.01%
ING Groep NV	0.01%
Migdal Insurance & Financial Holdings Ltd.	0.01%
Polar Capital Holdings Plc	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Unknown	6.86%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	77.14%
United Kingdom	7.52%
Canada	1.63%
Norway	1.26%
France	0.93%
Sweden	0.64%
Switzerland	0.6%
Japan	0.56%
Australia	0.5%
Germany	0.45%
Netherlands	0.27%
Hong Kong	0.24%
South Korea	0.24%
Denmark	0.2%
Luxembourg	0.18%
Individuals	0.16%
Ireland	0.11%
Belgium	0.11%
Italy	0.08%
Israel	0.05%
Liechtenstein	0.05%
Finland	0.05%
Austria	0.04%
Spain	0.04%
Singapore	0.03%
Czech Republic	0.02%
Slovenia	0.01%
South Africa	0.01%
China	0.01%
Taiwan	0.01%

Based on 1000 largest holdings

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.4%); - immunology diseases (9.8%); - neurology (3.3%): primarily drugs used in treating depression and schizophrenia; - other (2%). Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Employees

47,000

Sector

Pharmaceuticals

Calendar

06-20 - American Diabetes Association Scientific Conference - Abstract No - 144-OR

More about the company